Related Experiment Video
Updated: Aug 13, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Assessment of Circulating CCR6 Level in Acute Myocardial Infarction and its Association with Disease Severity
Amira Mohamed Noureldin Abdelrahman1, Amal Elmahdy Mohamed1, Ahmed Mahmoud Bendary2
1Department of Clinical and Chemical Pathology, Faculty of Medicine, Benha University, Egypt.
Insights
Higher expression of chemokine receptor CCR6 (Ccr6) on lymphocytes was found in acute myocardial infarction (AMI) patients. This finding suggests CCR6 may be a biomarker for AMI severity and coronary artery disease progression.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biomarker Discovery
Background:
- Acute myocardial infarction (AMI) involves systemic and intraplaque inflammation, often triggered by coronary artery thrombosis.
- The G-protein-coupled chemokine receptor (Ccr6) is expressed on leukocytes within atherosclerotic plaques and acts as an inflammation mediator.
Purpose of the Study:
- To quantify CCR6 lymphocyte expression in AMI patients.
- To investigate the association between CCR6 expression and AMI severity using the Gensini scoring system.
Main Methods:
- Flow cytometry was used to measure circulating CCR6+ lymphocytes in 25 AMI patients and 25 controls.
- Multivariate logistic regression analysis was employed to assess the predictive value of CCR6 for AMI.
Main Results:
- AMI patients exhibited a significantly higher percentage of CCR6+ lymphocytes compared to controls.
- CCR6 expression positively correlated with the Gensini score (GS), indicating a link to coronary artery disease (CAD) severity.
Conclusions:
- CCR6 is an independent biomarker for AMI.
- CCR6 may facilitate T lymphocyte recruitment, potentially destabilizing coronary lesions.
Background:
Acute myocardial infarction (AMI) pathophysiology is mediated by systemic, intraplaque myocardial inflammatory processes that occur mainly due to coronary artery thrombosis in an atherosclerotic plaque area. The G-protein-coupled chemokine receptor (Ccr6) is displayed on the surface of many types of leukocytes, that have been found in atherosclerotic plaques. It is a novel mediator of inflammation and immune response.
Objectives:
To determine CCR6 lymphocyte expression in AMI patients and its association with disease severity using the Gensini scoring system.
Methods:
25 AMI patients and 25 controls underwent flow cytometry to determine the percentage of circulating CCR6+ lymphocytes. To forecast AMI and determine how CCR6 expression relates to it, multivariate logistic regression analysis was used.
Results And Discussion:
There was a higher percentage of CCR6+ lymphocyte expression in AMI patients than in controls. In addition, CCR6 showed a significant positive correlation with the Gensini score (GS) in the AMI group then with the degree of coronary artery disease (CAD).
Conclusion:
The chemokine receptor CCR6 is an independent biomarker for AMI and mayplay a role as a mediator of T lymphocyte recruitment, which is associated with coronary lesion destabilization.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Myocarditis I: Introduction

